Winning Health(SZ:300253) Zheng Quan Zhi Xing·2025-06-19 13:06Core Viewpoint - The company announced the cancellation of certain stock options due to unmet performance conditions and the departure of some incentive recipients, impacting the 2022 stock option incentive plan [1][14][16]. Summary by Sections Stock Option Incentive Plan Overview - The 2022 stock option incentive plan was approved at the first extraordinary general meeting, allowing for a total of 33,000,000 stock options to be granted [1][4]. - The plan includes four exercise periods with specific performance targets based on net profit growth from 2021 [1][3]. Performance Conditions - For the first exercise period, the net profit growth rate must be at least 24% for 2022; for the second, at least 66% for 2023; for the third, at least 180% for 2025 [2][3]. - If the performance targets are not met, the corresponding stock options will be canceled [3][14]. Adjustments and Cancellations - Due to the departure of 23 recipients and performance issues, a total of 31,593,126 stock options will be canceled, including 2,657,855 options from departing recipients and 28,935,271 options due to unmet performance conditions [14][16]. - The exercise price for the stock options has been adjusted multiple times, currently set at 5.67 yuan per share [12][14]. Impact on the Company - The cancellation of stock options is not expected to affect the implementation of the 2022 incentive plan or the stability of the core management team, nor will it have a substantial impact on the company's financial status and operational results [14][15]. Legal and Procedural Compliance - The company has ensured that the cancellation process complies with relevant laws and regulations, and necessary approvals have been obtained [16][17].